Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
TipRanks Clinical-Trials-Auto-Generated Newsdesk
TipRanks Reporter
TipRanks’s Recent Articles
AstraZeneca Deepens COPD Insights in Moscow Registry
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. Registry Spotlight: Moscow COPD Insights Study Overview: Clinical...
11h ago
AZN
Takeda’s Mezagitamab ITP Extension Study: Long-Term Data That Matters for Investors
Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Study Overview: Takeda is running a...
11h ago
TAK
Takeda Advances Zasocitinib Trial in Vitiligo, Signaling Quiet but Important Pipeline Momentum
Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Study OverviewThis Phase 2 study, officially...
11h ago
TAK
Regeneron Broadens Women’s Health Pipeline With New Phase 2 FHA Trial
Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Study Overview Regeneron Pharmaceuticals is running a...
11h ago
REGN
Tyra Biosciences Advances BEACH301 Dose Escalation
Tyra Bioscience, Inc ($TYRA) announced an update on their ongoing clinical study. Tyra Biosciences’ BEACH301 trial, officially titled...
11h ago
TYRA
Takeda Advances Zasocitinib Trial in Painful Skin Disease, Sharpening Its Immunology Pipeline
Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda is running a phase 2...
11h ago
TAK
Prime Medicine Advances Wilson Disease Pipeline With New Prescreening Study
Prime Medicine, Inc. ($PRME) announced an update on their ongoing clinical study. Study OverviewPrime Medicine, Inc. is running...
11h ago
PRME
Bayer and Daiichi Sankyo Advance New Prostate Cancer Combo in Early-Stage Trial
Bayer AG ($BAYRY), Daiichi Sankyo Company ($DSKYF) announced an update on their ongoing clinical study. Study Overview: Daiichi...
11h ago
Pfizer and BioNTech Pause modRNA Shingles Ambitions
Biontech Se Sponsored Adr ($BNTX), Pfizer Inc ($PFE) announced an update on their ongoing clinical study. modRNA shingles...
11h ago
PFE
BNTX
Amgen’s FORTITUDE-301 Cancer Trial Completion: What Investors Should Watch in Bemarituzumab’s Next Act
Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s latest update on its FORTITUDE-301 trial...
11h ago
AMGN
Tafasitamab-Parsaclisib Trial Termination Tempers Incyte Outlook
Incyte ($INCY) announced an update on their ongoing clinical study. Tafasitamab-Parsaclisib Basket Trial Halted A Phase 1b/2a basket...
11h ago
INCY
Penumbra’s Indigo Post‑Market Study in Japan Reaches Completion, Setting the Stage for New Real‑World Data
Penumbra Inc. ($PEN) announced an update on their ongoing clinical study. Study Overview: Penumbra Inc. is running a...
11h ago
PEN
Micra AV Registry Reinforces Medtronic’s Leadless Pace
Medtronic ($MDT) announced an update on their ongoing clinical study. Micra AV Post-Approval Registry shows Medtronic tracking long-term...
11h ago
MDT
AstraZeneca’s AZD4063 Edges Forward in Rare Genetic Cardiomyopathy Trial: What Investors Should Watch
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. AstraZeneca Advances Early-Stage Heart Failure Study With AZD4063...
1d ago
AZN
Shionogi’s Oral RSV Antiviral Moves Forward: What Investors Should Watch in This Phase 2b Trial
Shionogi & Co ($SGIOF) announced an update on their ongoing clinical study. Study OverviewThis Phase 2b trial from...
1d ago
SGIOF
Insmed’s ENCORE Trial Reaches Key Milestone in MAC Lung Infection
Insmed ($INSM) announced an update on their ongoing clinical study. Study Overview: Insmed’s ENCORE trial (NCT04677569) is a...
1d ago
INSM
AstraZeneca Completes Key Drug–Interaction Study for AZD5004, Nudging Pipeline Risk Lower
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. Study OverviewAstraZeneca is running a Phase 1 clinical...
1d ago
AZN
AstraZeneca Tests Next-Gen Cell Therapy in Multiple Sclerosis: What Investors Should Watch
AstraZeneca ($AZN) announced an update on their ongoing clinical study. Study Overview AstraZeneca is running a Phase 1b...
2d ago
AZN
PharmaNutra Advances Phase 4 Trial Comparing Sucrosomial® Iron to Ferric Maltol in Iron-Deficient Women
PharmaNutra SpA ($IT:PHN) announced an update on their ongoing clinical study. Study OverviewThis phase 4 clinical study, officially...
2d ago
PHN
Moderna’s CMV Vaccine Extension Study Reaches Completion, Setting the Stage for Next Growth Catalyst
Moderna ($MRNA) announced an update on their ongoing clinical study. Moderna’s latest clinical update centers on a long‑term...
2d ago
MRNA
BioNTech and Bristol-Myers Squibb Advance Pumitamig Trial in Aggressive Brain Cancer
Bristol-Myers Squibb Company ($BMY), Biontech Se Sponsored Adr ($BNTX) announced an update on their ongoing clinical study. Study...
5d ago
BMY
BNTX
Takeda Advances TAK-279 in Ulcerative Colitis: What Investors Should Watch Next
Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Study Overview: Takeda is running a...
5d ago
TAK
Agios Expands Rare-Disease Pipeline With New Phase 1b PKU Study of AG-181
Agios Pharmaceuticals ($AGIO) announced an update on their ongoing clinical study. Study Overview Agios Pharmaceuticals is launching a...
5d ago
AGIO
Haleon Tests New Sensitivity Toothpaste in China: What Investors Should Watch
Haleon PLC Sponsored ADR ($HLN) announced an update on their ongoing clinical study. Haleon PLC has launched a...
5d ago
HLN
Takeda’s TAK-781 Trial Moves Forward in Rare Liver Disease, Quietly Building Long-Term Pipeline Value
Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda Pharmaceutical is advancing a new...
5d ago
TAK
Insulet’s Omnipod M Study Completes Key Milestone in Type 2 Diabetes Onboarding
Insulet ($PODD) announced an update on their ongoing clinical study. Study Overview: The trial, formally titled “Feasibility of...
5d ago
PODD
Arcturus’ ARCT-2304 Flu Vaccine Trial Reaches Phase 1 Finish Line: What Investors Should Watch Next
Arcturus Therapeutics ($ARCT) announced an update on their ongoing clinical study. Study Overview Arcturus Therapeutics is running a...
5d ago
ARCT
Bayer’s VERI‑China Heart Failure Study Nears Readout: What Investors Should Watch
Bayer AG ($BAYRY) announced an update on their ongoing clinical study. Study OverviewThe VERI‑China study is a multi-center,...
5d ago
BAYRY
Intellia’s NTLA-2001 Hits Key Milestone in ATTR Gene-Editing Trial, Raising the Stakes in Amyloidosis
Intellia Therapeutics Inc ($NTLA) announced an update on their ongoing clinical study. Study Overview – Intellia Therapeutics is...
5d ago
NTLA
Lilly Quietly Advances Next-Gen Obesity Candidate Eloralintide With Phase 1 Completion
Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. The phase 1 study titled...
5d ago
LLY
AstraZeneca Advances AZD5148: Early Safety Data Strengthens Its Infectious Disease Pipeline
AstraZeneca ($AZN) announced an update on their ongoing clinical study. Study Overview AstraZeneca is running a Phase I...
5d ago
AZN
GSK Advances Shigella Vaccine Program With Completed Phase 2 Trial in African Infants
GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. Study OverviewGlaxoSmithKline (GSK) is running a Phase 2...
5d ago
GSK
Celldex’s EvolvE Study Completion Sets Up Key Catalyst in Eosinophilic Esophagitis
Celldex Therapeutics ($CLDX) announced an update on their ongoing clinical study. Study Overview The EvolvE study, officially titled...
5d ago
CLDX
Ipsen’s Tazemetostat Trial in Tough Lymphoma Group Withdrawn: What Investors Should Know
Ipsen ($GB:0MH6) announced an update on their ongoing clinical study. Study Overview: Ipsen and Epizyme planned a phase...
5d ago
0MH6
GSK’s Long-Term Nucala Study in EGPA Nears the Finish Line: What Investors Should Know
GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. Study OverviewGlaxoSmithKline (GSK) is running an observational study...
5d ago
GSK
Bristol-Myers Squibb Expands Real-World Evidence for Mavacamten in China: What Investors Should Know
Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Study Overview Bristol-Myers Squibb is running...
6d ago
BMY
ConvaTec Advances ConvaVAC Ag+ Trial, Reinforcing Long-Term Wound Care Growth Story
ConvaTec Group plc ($GB:CTEC) announced an update on their ongoing clinical study. ConvaTec Group plc is preparing a...
6d ago
CTEC
Takeda’s Zasocitinib Trial in Psoriatic Arthritis Moves Forward, Raising New Pipeline Upside
Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda is advancing a key late-stage...
6d ago
TAK
Corcept’s TRIDENT Trial: Early Oncology Bet in Metastatic Pancreatic Cancer
Corcept Therapeutics ($CORT) announced an update on their ongoing clinical study. Corcept Therapeutics is running a mid-stage (Phase...
6d ago
CORT
Takeda Deepens Real-World Safety Data for Adzynma in Ultra-Rare cTTP Market
Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Study OverviewThis post-authorization safety study, officially...
6d ago
TAK
Syndax’s Revumenib Solid-Tumor Trial Completion: What Investors Should Watch Next
Syndax Pharmaceuticals Inc. ($SNDX) announced an update on their ongoing clinical study. Syndax’s Revumenib Study Offers New Angle...
6d ago
SNDX
Takeda Advances Zasocitinib Phase 3 Trial in Psoriatic Arthritis: What Investors Should Know
Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda’s latest phase 3 study, officially...
7d ago
TAK
Takeda’s Phase 3 Mezagitamab Trial in ITP Moves Forward, Keeping Pipeline Hopes in Focus
Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Study OverviewTakeda is running a late-stage...
7d ago
TAK
Cochlear’s Fully Implantable Implant Trial: What the New TI1132 Study Means for Investors
Cochlear Limited ($CHEOF) announced an update on their ongoing clinical study. Cochlear’s Next Step: Fully Implantable Hearing Tech...
7d ago
CHEOF
GSK Advances Liver Disease Pipeline With New Efimosfermin Alfa Trial
GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. Study Overview GlaxoSmithKline (GSK) is launching a Phase...
7d ago
GSK
Takeda’s TAK-330 Nears Key Milestones in High-Stakes Emergency Surgery Trial
Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda is running a Phase 3...
7d ago
TAK
Sanofi Advances PCV21 Vaccine Trial in Sickle Cell Children, Targeting an Edge in Pneumococcal Protection
Sanofi SA ($SNY) announced an update on their ongoing clinical study. Study Overview: Sanofi is running a late-stage...
7d ago
SNY
Corcept’s Nenocorilant Combo Study Moves Forward, Expanding Its Oncology Ambitions
Corcept Therapeutics ($CORT) announced an update on their ongoing clinical study. Study OverviewThis study, officially titled “A Phase...
7d ago
CORT
Zanubrutinib Update: What BeiGene’s BTK Intolerance Study Means for Oncology Investors
BeOne Medicines ($ONC) announced an update on their ongoing clinical study. Study Overview: This Phase 2 study, officially...
7d ago
ONC
Aroa Biosurgery’s Symphony Trial Completion: What Diabetic Ulcer Data Could Mean for AU:ARX
Aroa Biosurgery Ltd ($AU:ARX) announced an update on their ongoing clinical study. Study Overview: This completed clinical study,...
7d ago
ARX
SHOW MORE
You need to enable JavaScript to run this app.
